Search

everythinglearnresearchcommunity

for

Search:↓

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Australia needs better dermatological guidelines for gender-diverse patients.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Poor sleep may lead to hair loss, and hair loss may affect sleep.

More research is needed to understand how testosterone is maintained in adult males.

Stem cell treatments show promise for hair loss but need more research.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.